Global Blood Therapeutics | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (32)

Latest Posts

About This Stock More About This Stock
Biotech Stocks Well-Positioned For The Fourth Quarter
Article By: Tarun Chandra, CFA
Wednesday, October 12, 2022 1:12 AM EDT
The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.
In this article: NVO, PFE, AMGN, BIIB, CCXI, BLUE, GBT, RYTM, KRTX, FMTX, AKRO
Read
AskSlim Market Week - Friday, May 21
Video By: Steve Miller
Friday, May 21, 2021 8:28 PM EDT
Technical and cycle analysis of US markets over the past week and what to expect, plus Shanghai and FTSE previews.
In this video: SPX, QQQ, DIA, SPY Also: GBT, IONS, IOVA
Watch
Why Biotech ETFs Are Surging To New Highs
Video By: Neena Mishra
Tuesday, December 10, 2019 10:00 PM EDT
We have seen very strong M&A activity in the biotech space of late and the trend is expected to continue as big pharmaceutical companies are trying to gain an edge in the increasingly competitive cancer treatment market.
In this video: XBI, BBC, SBIO, ARKG Also: MRK, NVS, SNY, ARQL, MDCO, THOR, GBT, AUPH, CRSP
Watch
3 Promising Gene Therapy Stocks
Article By: Tarun Chandra, CFA
Saturday, May 25, 2019 9:45 PM EDT
Investor interest in gene therapy companies has been on the rise. Here is a look at 3 promising small cap gene therapy companies.
In this article: BOLD, VYGR, QURE Also: SRPT, PTCT, BLUE, ONCE, EDIT, NTLA, CRSP, RGNX, SLDB, FIXX, MGTX, NVS, RHHBY, GOOG, ACAD, ARNA, ARRY, CBPO, PCRX, AMRN, SAGE, MRNA, GWPH, ASND, RARX, BHVN, MRTX, DNLI, CHRS, MDCO, ARWR, ZIOP, TGTX, PTLA, GBT, AXSM
Read
Morning Call For Friday, Dec. 7
Article By: Jim Van Meerten
Friday, December 7, 2018 7:56 AM EDT
Dec E-mini S&Ps (ESZ18 -0.46%) this morning are down -0.58% ahead of this morning's U.S. Nov non-farm payroll report.
In this article: AVGO, CMTL, EXPD, LULU, ULTA, UNFI, WDFC, ZUMZ, ZEN, GBT, AOBC, QTNT, DOMO
Read

Latest Tweets for $GBT

No tweets yet!

PARTNER HEADLINES